Acquisition Opportunity MAK-SYSTEM has recently been acquired by Invitahealth, signaling a broader end-to-end blood management capability and potential for expanded service offerings and global reach that sales teams can leverage to cross-sell integrated solutions.

Strategic Partnerships Long-standing partnerships with major blood services and centralized networks (Northern Ireland, NYBC, NYBCe) indicate a proven track record with public health entities and a strong foothold in regulated environments, presenting opportunities to expand into similar regional blood banks and health systems.

Regulated Tech Focus Expertise in delivering configurable software for tissue, gene, and cell therapies within regulated environments suggests a high suitability for selling additional compliance, data integrity, and workflow automation tools to biorepositories, transplantation networks, and biopharma manufacturers.

Cloud Platform Momentum Launch of a cloud platform for blood and biologics in collaboration with AWS highlights scalable, secure cloud-based solutions that can be upsold as cloud migration, security, and managed services to healthcare IT buyers seeking modernization.

Global Expansion Recent ISCT engagement and Invitahealth international growth point to opportunities in global markets and multi-national health organizations, where MAK-SYSTEM’s technologies can be positioned as part of end-to-end blood supply chain digital transformation.